FDA — authorised 5 July 2013
- Application: NDA205764
- Marketing authorisation holder: LINDE NORTH AMERICA INC
- Local brand name: CARBON DIOXIDE, USP
- Indication: GAS — INHALATION
- Status: approved
FDA authorised CARBON DIOXIDE, USP on 5 July 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 5 July 2013; FDA authorised it on 5 July 2013; FDA authorised it on 7 September 2013.
LINDE NORTH AMERICA INC holds the US marketing authorisation.